EdgeScore

M.RO · BVB

MedLife: financial statements

Financially weak · see the checkFigures in RON, fiscal years

Revenue and net income

Revenue 2020: 1.1B RONNet income 2020: 56.7M RON2020Revenue 2021: 1.4B RONNet income 2021: 103M RON2021Revenue 2022: 1.8B RONNet income 2022: 32.2M RON2022Revenue 2023: 2.2B RONNet income 2023: 3.7M RON2023Revenue 2024: 2.7B RONNet income 2024: 25.0M RON2024Revenue 2025: 3.2B RONNet income 2025: 11.3M RON2025
RevenueNet income

Operating and free cash flow

Operating cash flow 2020: 129M RONFree cash flow 2020: 45.5M RON2020Operating cash flow 2021: 227M RONFree cash flow 2021: 136M RON2021Operating cash flow 2022: 185M RONFree cash flow 2022: 35.5M RON2022Operating cash flow 2023: 184M RONFree cash flow 2023: -17.8M RON2023Operating cash flow 2024: 286M RONFree cash flow 2024: 48.9M RON2024Operating cash flow 2025: 223M RONFree cash flow 2025: 3.5M RON2025
Operating cash flowFree cash flow

Margins

Operating 2020: 10.1%Operating 2021: 12.0%Operating 2022: 5.2%Operating 2023: 4.1%Operating 2024: 5.2%Operating 2025: 5.0%Net 2020: 5.3%Net 2021: 7.2%Net 2022: 1.8%Net 2023: 0.2%Net 2024: 0.9%Net 2025: 0.4%202020212022202320242025
GrossOperatingNet

Returns

ROE 2020: 23.5%ROE 2021: 30.3%ROE 2022: 7.7%ROE 2023: 0.9%ROE 2024: 5.8%ROE 2025: 2.3%ROIC 2020: 14.3%ROIC 2021: 21.7%ROIC 2022: 7.5%ROIC 2023: 5.5%ROIC 2024: 7.3%ROIC 2025: 7.4%ROA 2020: 4.8%ROA 2021: 7.2%ROA 2022: 1.5%ROA 2023: 0.1%ROA 2024: 0.8%ROA 2025: 0.3%202020212022202320242025
ROEROICROA

Income statement

RON202020212022202320242025Last year
Revenue1.1B RON1.4B RON1.8B RON2.2B RON2.7B RON3.2B RON+17%
Operating income109M RON172M RON94.2M RON91.5M RON140M RON159M RON+13%
EBITDA212M RON286M RON247M RON289M RON395M RON445M RON+13%
Interest expense23.3M RON27.5M RON42.5M RON82.2M RON103M RON96.6M RON-6%
Profit before tax78.6M RON135M RON49.6M RON4.3M RON39.1M RON19.1M RON-51%
Income tax14.8M RON22.5M RON12.1M RON8.5M RON22.3M RON23.0M RON+3%
Net income56.7M RON103M RON32.2M RON3.7M RON25.0M RON11.3M RON-55%

Cash flow

RON202020212022202320242025Last year
Operating cash flow129M RON227M RON185M RON184M RON286M RON223M RON-22%
Capital expenditure83.1M RON91.5M RON149M RON201M RON237M RON219M RON-7%
Free cash flow45.5M RON136M RON35.5M RON-17.8M RON48.9M RON3.5M RON-93%
Depreciation & amortization103M RON114M RON152M RON197M RON255M RON286M RON+12%

Balance sheet

RON202020212022202320242025Last year
Cash82.0M RON136M RON89.1M RON100M RON113M RON176M RON+56%
Inventory53.1M RON74.2M RON98.8M RON110M RON149M RON153M RON+3%
Current assets279M RON383M RON465M RON534M RON659M RON703M RON+7%
Total assets1.2B RON1.4B RON2.2B RON2.6B RON3.0B RON3.3B RON+8%
Current liabilities314M RON415M RON576M RON700M RON976M RON885M RON-9%
Financial debt461M RON499M RON859M RON1.1B RON1.3B RON1.5B RON+17%
Total liabilities915M RON1.0B RON1.7B RON2.1B RON2.5B RON2.7B RON+8%
Shareholders' equity241M RON338M RON417M RON415M RON433M RON484M RON+12%
Net debt379M RON363M RON770M RON1.0B RON1.1B RON1.3B RON+14%

Dividend profile

Paying in a row
6+ years
Raised in a row
0 years
Growth per year
n/a
Paid out of profit
17.9%
Paid out of free cash
20.7%

Without share prices EdgeScore shows no dividend yield.

Dividends

RON202020212022202320242025Last year
Dividends paid702K RON70.0K RON137K RON1.4M RON2.1M RON3.7M RON+79%
Dividends / net income1.2%0.1%0.4%37.9%8.3%32.9%
Dividends / free cash flow1.5%0.1%0.4%—4.2%105.2%

Ratios

202020212022202320242025Last year
Operating margin10.1%12.0%5.2%4.1%5.2%5.0%
Net margin5.3%7.2%1.8%0.2%0.9%0.4%
Return on equity23.5%30.3%7.7%0.9%5.8%2.3%
Return on assets4.8%7.2%1.5%0.1%0.8%0.3%
Return on invested capital14.3%21.7%7.5%5.5%7.3%7.4%
Debt / equity1.911.482.062.702.923.06
Net debt / EBITDA1.8x1.3x3.1x3.5x2.9x2.9x
Interest coverage4.7x6.3x2.2x1.1x1.4x1.6x
Current ratio0.890.920.810.760.670.79
Quick ratio0.720.740.640.610.520.62

Data source: Bucharest Stock Exchange (ESEF), company annual reports. Lines a company does not report are left empty. Free cash flow is operating cash flow minus capital expenditure. Ratios use the same formulas as the EdgeScore check.

For information and education only. Not investment advice. Data may contain errors.